By learning more about the flows generated by a biofilm, researchers may discover new ways to cut off its supply of nutrients.
The cost of treating animal-related injuries in U.S. emergency rooms is about $1.2 billion per year, a new Stanford study shows.
New research examines how Zika viruses enter cells and shows that their behavior is different than that of some related viruses.
The U.S. Preventative Services Task Force encourages those who are at high risk of contracting HIV to take a daily pre-exposure drug.
Stanford chemists have developed a potential new strategy for fighting antibiotic-resistant bacterium — adding a new molecule onto an existing antibiotic.
One hundred years after the 1928 influenza epidemic, flu remains a threat to society today, several Stanford emergency medicine clinicians explain.
Decision scientist Mehlika Toy is working with the WHO to help eliminate the public health burden of hepatitis B by the year 2030.
Stanford scientists have found that viral infections shaped human genome evolution after interbreeding with Neanderthals 50,000 years ago.
The ratio between a certain types of immune cells is able to predict whether latent TB will shift into an active infection, new research has found.
A new imaging technology that harnesses fluorescence allows scientists to detect tuberculosis in an hour and to measure drug efficacy.
Found in about half of all bacterial species, the cell membrane that surrounds the cell wall may be more critical for survival than previously thought.
Targeted screening can cut hepatitis B related deaths in the U.S. by half - and save money.
The American Cancer Society joins forces with National Cancer Institute-designated cancer centers to promote the HPV vaccine and eliminate cervical cancer.
Antiretroviral therapy, a breakthrough treatment for HIV infection, suppresses the levels of circulating HIV viral particles in the blood. When it works, cancer rates drop, according to a new study. Still, even when the therapy is successful, HIV-positive individuals retain elevated rates of cancer.
Researchers have used an ultrafast, intense X-ray laser to observe how Mycobacterium tuberculosis bacteria attack antibiotics, making the drugs ineffective.
A hitherto unheralded set of telltale enzymes may prove to be perfect targets for shooting down a gang of nasty bacterial pathogens collectively called S. aureus.
